The phrase "and efficacy of current" is not complete and lacks context, making it difficult to determine its correctness in written English.
It could be used in discussions related to the effectiveness of current methods, practices, or treatments, but it needs additional context to be fully understood.
Example: "The study focuses on the safety and efficacy of current medical treatments for the disease."
Alternatives: "and effectiveness of current" or "and performance of current".
Incidence of degeneration, degree of impairment, and efficacy of current treatments are critical factors in choosing a target for joint bioengineering.
We conclude that almost one out of 20 placebo treated patients discontinued treatment due to AEs, indicating a significant nocebo in trials for depression treatment adversely affecting adherence and efficacy of current treatments in clinical practice, with additional implications for trial designing.
OBJECTIVES: To test the feasibility and efficacy of current guidelines for multimodal exercise programs in older adults.
However, the safety and efficacy of current vaccines are still significant concerns.
Such an approach needs urgent development and testing to improve the safety and efficacy of current CLC systems.
The field of transfusion medicine has experienced much controversy surrounding the safety and efficacy of current transfusion practices.
However after all, our pilot clinical trial is a very preliminary exploratory study so the safety and efficacy of the current strategy still need additional verification in a much larger cohort.
The results of this study also indicate a prevailing lack of confidence of market actors regarding the integrity and efficacy of the current active standards due to their relatively recent establishment and few experiences with forest projects that have lifetimes and crediting periods of several decades.
Thus, the identification of specific and sensitive biomarkers is extremely important to facilitate early and differential diagnosis, monitor disease progression, and assess efficacy of current and future treatments.
Treatment of ACC remains challenging and the efficacy of current therapies such as mitotane and etoposide has been dismal.
Given concerns regarding adverse effects of blood product transfusion and limited efficacy of current antifibrinolytics, procoagulant medications, including recombinant factor VIIa (rFVIIa) and factor eight inhibitor bypass activity (FEIBA), increasingly have been used in managing refractory bleeding.
